Scientists have identified the precise molecular trigger behind a rare blood-clotting disorder linked to certain adenovirus-based COVID-19 vaccines and, in rare cases, natural adenovirus infection. Researchers led by Flinders University, working with international collaborators, have clarified how a rare blood…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.